NCT04603807 2026-02-27A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) MetastasesHoffmann-La RochePhase 3 Active not recruiting220 enrolled